Tuesday, May 26, 2026

The FDA may approve a booster injection of the COVID-19 vaccine this week


A report quoted a source familiar with the discussion as saying that the US Food and Drug Administration may authorize a third dose of the COVID-19 vaccine within this week for immunocompromised persons.

This move may allow some disadvantaged Americans to receive booster injections of the current two doses of Pfizer and Moderna vaccines. However, the source said that the FDA can still not announce the third shot for the time being. CNN Report.

The report quoted an FDA spokesperson as saying: “The FDA is closely monitoring the data because it can be obtained from studies that administer additional doses of the approved COVID-19 vaccine to immunocompromised individuals.” The official added: “The The agency is working with the Centers for Disease Control and Prevention to evaluate potential options on this issue and will share information in the near future.”

A team of vaccine consultants from the Centers for Disease Control and Prevention is scheduled to meet on Friday to discuss a third dose of the COVID-19 vaccine for people with compromised immune systems.

According to estimates CDC, 2.7% of all adults in the United States, or about 9 million Americans, are immunocompromised. The agency defines immunocompromised patients as organ transplant recipients, people receiving cancer treatment, HIV-infected people, and solid tumor patients.

in a Small research A study published in June by Johns Hopkins University researchers showed that among 30 organ transplant recipients who received two doses of Moderna or Pfizer vaccine, at least 24 did not develop antibodies against COVID-19. Although the other six patients developed antibodies after vaccination, the low levels still made them vulnerable to the virus.

After the researchers gave the patient the third dose of the COVID-19 vaccine, 8 of the 24 patients who had no antibodies before increased. The six patients with low antibody levels after the second injection also increased after the booster dose.

“For me, the main message here to transplant patients and immunosuppressed patients is the message of hope,” Dr. Dorry Segev, author of the study, research associate director and professor of surgery at Johns Hopkins University, was quoted as saying NBC News.

If the FDA grants emergency use authorization for booster injections, it may not apply to healthy individuals who are fully vaccinated.

Last week, the Mississippi Department of Health recommended that health care providers in the state vaccinate patients with weakened immune systems with a third dose. Hill.



Court documents show that 46-year-old Steven R. Brandenburg deliberately removed the Moderna vaccine vial from the refrigerator
Photo: AFP/Apgomez





Source link

Related articles

Unlock Unlimited Whitening: A New Era Beyond Limitation Zoom Dental

Teeth whitening is one of the most sought-after dental...

Anthropic AI Stock Gains Momentum with Investors

With Anthropic AI capturing attention without a public symbol, what hidden opportunities lie for those eager to invest before the IPO?

AI Advancements 2025: Exciting Future Predictions

As AI advancements in 2025 promise breakthroughs like enhanced capabilities and memory optimization, experts wonder: Are we truly prepared for what's next?

BitPay Stocks: Understanding Private Investment Dynamics

Curious about BitPay stocks? Here's what you need to know before you consider this intriguing investment opportunity, but what's next?

AI Tools for Forecasting: Boosting Prediction Success

Exploring AI tools for forecasting unveils a realm of accuracy and industry-specific applications. But which tool holds the key to...?
spot_imgspot_img